Salt Lake City, UT, Aug. 18, 2017 -- SALT LAKE CITY, August 21, 2017 /PRNewswire/--ARUP Laboratories and IllumiCare have announced a strategic collaboration to provide clinicians with content and decision support.
|
|||||
In an era of rising patient deductibles and health insurance premiums, it is ever more important to spend healthcare dollars efficiently. Physicians are being asked to provide “value-based care,” yet they are not routinely told what things cost.
“ARUP has long been an advocate of empowering clinicians with current testing knowledge and providing unparalleled guidance through ARUP’s utilization management services,” says Andrew Fletcher, MD, the ARUP medical director of Consultative Services. “We are excited to share the research and expertise of our 90+ medical directors.”
IllumiCare’s Smart Ribbon is a non-intrusive ribbon of information that hovers over or embeds within the electronic medical record and provides real-time visibility of the cumulative risk and financial impact of tests and medications being ordered during the course of care. Studies show that displaying cost and risk of patient harm at the point of care causes physicians to provide safer and more efficient care.
“This partnership allows us to bring the expertise and best practice recommendations of a leading national reference laboratory to physicians at the point of care,” says G.T. LaBorde, CEO of IllumiCare. “Clinicians are being asked to remove waste and provide better care at a lower cost. The Smart Ribbon, with ARUP, provides valuable content for informed decision making, helping to reduce clinical and cost variation during the treatment of care.”
IllumiCare and ARUP together recognize that behind each lab test is a patient that may experience discomfort and a risk of harm. This collaboration seeks to ensure that patients receive the right test at the right time.
Media Contacts:
Cyndee Holden, (801) 583-2787, ext. 3318, [email protected]
G.T. LaBorde, (205) 719-8595, [email protected]
About ARUP Laboratories
Founded in 1984, ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation's top university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®. ARUP is ISO 15189 CAP accredited.
About IllumiCare
Founded in 2014, IllumiCare displays clinical, financial, and patient safety data in a non-intrusive, EMR agnostic “ribbon.” The data displayed can be customized by facility, care setting, user type, and patient type. Cost transparency, predictive analytics, population health and other analytics are powerful tools. They are most effective when provided to your clinicians in real-time, at the point of care.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/86603cd9-a1e7-4efb-8ae8-27579dc70b74
Catherine Arnold ARUP Laboratories (801) 583-2787, ext. 3635 [email protected]


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



